Insider Transactions in Q4 2022 at Fennec Pharmaceuticals Inc. (FENC)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 30
2022
|
Rosty Raykov |
SELL
Open market or private sale
|
Direct |
10,000
-2.21%
|
$90,000
$9.64 P/Share
|
|
Dec 30
2022
|
Robert Andrade CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,500
-3.54%
|
$49,500
$9.61 P/Share
|
|
Dec 29
2022
|
Rosty Raykov |
SELL
Open market or private sale
|
Direct |
5,000
-2.15%
|
$45,000
$9.65 P/Share
|
|
Dec 29
2022
|
Robert Andrade CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,500
-3.42%
|
$49,500
$9.57 P/Share
|
|
Dec 28
2022
|
Rosty Raykov |
SELL
Open market or private sale
|
Direct |
13,740
-5.57%
|
$123,660
$9.59 P/Share
|
|
Dec 28
2022
|
Robert Andrade CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
11,000
-6.41%
|
$99,000
$9.61 P/Share
|
|
Nov 17
2022
|
Chris A Rallis |
SELL
Open market or private sale
|
Direct |
333
-1.1%
|
$2,331
$7.99 P/Share
|
|
Oct 20
2022
|
Chris A Rallis |
SELL
Payment of exercise price or tax liability
|
Direct |
2,068
-6.38%
|
$16,544
$8.26 P/Share
|
|
Oct 20
2022
|
Chris A Rallis |
BUY
Exercise of conversion of derivative security
|
Direct |
4,762
+12.81%
|
$4,762
$1.05 P/Share
|